ADHD Medication Generic Drug Problems & Shortages

How to actually navigate the current ADHD medication shortage and the generic manufacturing variability underneath it. Jonathan Murphy, PMHNP-BC, walks through what the Reddit narrative gets wrong, why Adderall XR generics have the least reliable quality control, and how to work the pharmacy system to find your medication.

This episode covers:

• The August 2026 ADHD medication shortage compared to the 2020-2021 shortage and why this one is harder to work around
• Why the "I can't function" Reddit echo chamber distorts the actual choices patients have
• Why medication optimization matters more than any specific generic manufacturer and what optimization would do to shortages overall
• The Adderall XR generic manufacturing problem: many manufacturers, low quality control, high variability
• Why patients should never lock into "I have to have brand X" thinking when generic manufacturers shift constantly
• The medications with better quality control: brand-only, Dexedrine Spansules, Vyvanse, Mydayis, Focalin, and the various methylphenidate extended-release options
• Why Concerta's spherical versus oblong tablet distinction matters for absorption
• The pharmacy hierarchy: pharmacy-first stores versus grocery-store pharmacies (Safeway, Fred Meyer, Hannaford) versus big-box (Costco, Sam's Club) versus mail order (Express Scripts)
• The polite pharmacy-transfer script that gets a prescription moved without provider intervention
• Why one pharmacist saying "we'll never have it" is not a reliable signal about the wider supply
• The middleman supplier reality: one pharmacy on a block is out while the one across the street has stock
• When to switch medications entirely: Mydayis, Vyvanse, Dexedrine, or the methylphenidate family as alternatives to Adderall XR
• Why the controlled substance barriers happen before pickup and picking up your medication is not a suspect act
• Why consistency matters more than the "best" medication, and how daily consistency compounds into new habits and new neural pathways
• This is the fifteenth episode of Actually ADHD. Previous episodes covered the optimization blueprint, the medication walkthrough, the Goldilocks Zone framework, the seven reasons medication fails, ADHD and identity, the ADHD Matrix, the peer clinician perspective, the DRT origin story, the Focus Path YouTube channel reflection, the Friction and Flow talk, the guanfacine controversy, the Vyvanse deep dive, and the Ride Out or Bail side effects framework.

The book The Process: An Adult's Guide to ADHD Medication is available on Amazon: https://www.amazon.com/dp/B0H2Z6PM4T

Find the YouTube channel Focus Path | PMHNP-BC for the full clinical education catalog.